His primary areas of study are Immunology, Autoantibody, Cell biology, Internal medicine and B cell. His studies in CD19, Autoimmunity, Autoimmune disease, Antigen and Regulatory B cells are all subfields of Immunology research. The study incorporates disciplines such as Fibrosis and Systemic scleroderma in addition to Autoantibody.
His studies in Cell biology integrate themes in fields like Inflammation, Epidermal growth factor and B-cell receptor. His work deals with themes such as Gastroenterology, Endocrinology and Antibody, which intersect with Internal medicine. Manabu Fujimoto has researched B cell in several fields, including Molecular biology, Naive B cell and T cell.
His primary areas of investigation include Immunology, Internal medicine, Pathology, Dermatology and Autoantibody. His Immunology research focuses on Fibrosis and how it connects with Bleomycin. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology and Oncology.
His study focuses on the intersection of Autoantibody and fields such as Dermatomyositis with connections in the field of Interstitial lung disease, Polymyositis and Myositis. His Connective tissue disease research incorporates elements of Pulmonary fibrosis, Serology, Scleroderma and Immunopathology. His research is interdisciplinary, bridging the disciplines of B cell and Autoimmunity.
Dermatology, Dermatomyositis, Immunology, Internal medicine and Cancer research are his primary areas of study. His research in Dermatology intersects with topics in Retrospective cohort study and Skin manifestations. His Dermatomyositis research includes elements of Myositis, Autoantibody, Antibody, Family medicine and Polymyositis.
His research brings together the fields of Disease and Immunology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Melanoma and Oncology. His Cancer research study frequently links to adjacent areas such as Immune system.
Manabu Fujimoto focuses on Dermatomyositis, Internal medicine, Immunology, Dermatology and Cancer research. The Dermatomyositis study combines topics in areas such as MEDLINE, Myositis, Autoantibody, Antibody and Family medicine. His Antibody research integrates issues from Inflammatory myopathy and Interstitial lung disease.
His Inflammatory myopathy study combines topics in areas such as Molecular biology, Adoptive cell transfer and Autoimmunity. The various areas that Manabu Fujimoto examines in his Internal medicine study include Gastroenterology and Melanoma. The concepts of his Immunology study are interwoven with issues in Human skin, Netherton syndrome and Stratum granulosum.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
Koichi Yanaba;Jean-David Bouaziz;Karen M. Haas;Jonathan C. Poe.
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Takashi Matsushita;Koichi Yanaba;Jean-David Bouaziz;Manabu Fujimoto.
Journal of Clinical Investigation (2008)
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
Atsuyuki Igarashi;Kiyoko Nashiro;Kanako Kikuchi;Shinichi Sato.
Journal of Investigative Dermatology (1996)
Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.
E Matsuura;Y Igarashi;M Fujimoto;K Ichikawa.
Journal of Immunology (1992)
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M;Fujimoto M;Kikuchi K;Takehara K.
The Journal of Rheumatology (1997)
Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity
Shinichi Sato;Minoru Hasegawa;Manabu Fujimoto;Thomas F. Tedder.
Journal of Immunology (2000)
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.
Rei Watanabe;Nobuko Ishiura;Hiroko Nakashima;Yoshihiro Kuwano.
Journal of Immunology (2010)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji;M. Fujimoto;M. Hasegawa;M. Kondo.
Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells
Shinichi Sato;Manabu Fujimoto;Minoru Hasegawa;Kazukiko Takehara.
Arthritis & Rheumatism (2004)
CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
Eriko Saito;Manabu Fujimoto;Minoru Hasegawa;Kazuhiro Komura.
Journal of Clinical Investigation (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: